Phenotype-Genotype Correlations in Myelin Protein Zero (MPZ) Variants

A comprehensive research paper by Laurini et al. (2025) investigating phenotype-genotype correlations in early-onset Charcot-Marie-Tooth type 1B (CMT1B), a neuropathy linked to Myelin Protein Zero (MPZ) variants. The authors analyzed data from a large cohort of 75 Italian patients to understand how different MPZ mutations affect disease severity and progression, categorizing variants as either destabilizing or non-destabilizing. Key findings indicate that destabilizing variants are associated with an earlier onset, more severe clinical features, and a potentially faster rate of progression, which was quantitatively supported by the inverse correlation between predicted protein destabilization ($ΔΔG$ values) and clinical severity scores (CMTES). The study emphasizes that this molecular classification is critical for predicting patient outcomes and informing the development of targeted therapeutic strategies, particularly those aimed at modulating the unfolded protein response (UPR) pathway.